- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04134546
Early Versus Late Intervention After Biliary Tract Injury Post Cholecystectomy
Bile duct injury following cholecystectomy is an iatrogenic catastrophe associated with significant peri operative morbidity and mortality(1, 2) reduced long term survival(3) and quality of life(4, 5) and high rates of subsequent litigation6. It should be regarded as preventable.
The advent of laparoscopic cholecystectomy has resulted in a resurgence of interest in bile duct injury and its subsequent management. Population based studies(6.7) suggest a significant increase in the incidence of injury (0•1 to 0•5 per cent) following the implementation of the laparoscopic approach(8) Bile duct injury should be regarded as preventable, but over 70 per cent of surgeons regard it as unavoidable(9). Although most injuries occur within the surgeon's first 100 laparoscopic cholecystectomies, one third happen after the surgeon has performed more than 200; it is more than inexperience that leads to bile duct injury(10). It has been suggested that the commonest cause of common bile duct injury is misidentification of biliary anatomy (70-80 per cent of injuries)(11,12),a reduction in risk if surgeons perform routine intraoperative cholangiography Recognition of bile duct injury at the time of cholecystectomy allows an opportunity for the hepatobiliary surgeon to assess its severity and the presence of any vascular injury
Study Overview
Detailed Description
Bile duct injury following cholecystectomy is an iatrogenic catastrophe associated with significant peri operative morbidity and mortality(1, 2) reduced long term survival(3) and quality of life(4, 5) and high rates of subsequent litigation6. It should be regarded as preventable.
The advent of laparoscopic cholecystectomy has resulted in a resurgence of interest in bile duct injury and its subsequent management. Population based studies(6.7) suggest a significant increase in the incidence of injury (0•1 to 0•5 per cent) following the implementation of the laparoscopic approach(8) Bile duct injury should be regarded as preventable, but over 70 per cent of surgeons regard it as unavoidable(9). Although most injuries occur within the surgeon's first 100 laparoscopic cholecystectomies, one third happen after the surgeon has performed more than 200; it is more than inexperience that leads to bile duct injury(10). It has been suggested that the commonest cause of common bile duct injury is misidentification of biliary anatomy (70-80 per cent of injuries)(11,12),a reduction in risk if surgeons perform routine intraoperative cholangiography Recognition of bile duct injury at the time of cholecystectomy allows an opportunity for the hepatobiliary surgeon to assess its severity and the presence of any vascular injury
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients with post cholecystectomy biliary tract injury admitted at Assuit university hospital at the period of the study
Exclusion Criteria:
- Any case with biliary leakage not post cholecystectomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: group with biliary injury
group for Early versus late intervention after biliary tract injury post cholecystectomy
|
Early versus late intervention after biliary tract injury post cholecystectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
faliure of interventon
Time Frame: two months
|
By mesurment liver functon as direct billirubin
|
two months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
plan for improving
Time Frame: two months
|
by mesurment of liver function as AST
|
two months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- biliary tract injury
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biliary Fistula
-
University of Oran 1UnknownBile Leak | Anastomotic Leak Biliary | Biliary Tract FistulaAlgeria
-
University Hospital, ToulouseCompleted
-
University of MilanCompleted
-
Centre Hospitalier Universitaire, AmiensUnknown
-
University of MilanCompletedHepatectomy | Bile Leak | Hepatic Resection | Biliary Fistula | Liver ResectionItaly
-
Tecnologico de MonterreyCompleted
-
Oslo University HospitalActive, not recruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Fistula | Biliary Tract Cancer | Duodenal CancerNorway
-
Central Hospital, Nancy, FranceCompletedSepsis | Pancreatic Cancer | Fistula | Bile Duct Cancer | Delayed Gastric Emptying | Post-Op Complication | Duodenal Cancer | Post-Op Infection | Bile Duct; Obliteration | Fistula, BiliaryFrance
-
Zagazig UniversityCompleted
-
Rigshospitalet, DenmarkCompletedPancreas Cancer | Biliary Fistula | Surgery-ComplicationsDenmark
Clinical Trials on CBD exoloration
-
Hartford HospitalYale UniversityRecruiting
-
Johns Hopkins UniversityCultivate BiologicsCompleted
-
University of Texas at AustinWay West Wellness; SunFlora.IncSuspendedAnger | Sleep Disturbance | Anxiety Depression | Substance Abuse | Alcohol Abuse | Stress ReactionUnited States
-
Universidad de GranadaActive, not recruiting
-
Advanced Pain and Rehab SpecialistsHemp synergisticsNot yet recruitingInsomnia | Anxiety | Opioid Use | Pain, Chronic | CBDUnited States
-
University of Texas at AustinSuspendedPost Traumatic Stress DisorderUnited States
-
University of CalgaryNot yet recruitingChronic Migraine
-
Pure GreenRecruitingOsteoarthritis, KneeUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA); University of North Carolina, Chapel... and other collaboratorsCompleted
-
Canopy Growth CorporationNM Clinical Research & Osteoporosis Center, Inc.Terminated